Home
About
Overview
Sharing Data
ORCID
Help
History (15)
Patterns and predictors of first-line chemotherapy use among adults with advanced non-small cell lung cancer in the cancer research network.
The role of hormone replacement therapy in the risk for breast cancer and total mortality in women with a family history of breast cancer.
Material and psychological financial hardship related to employment disruption among female adolescent and young adult cancer survivors.
Adiposity, post-diagnosis weight change, and risk of cardiovascular events among early-stage breast cancer survivors.
Changes in bone mineral density in women with breast cancer receiving aromatase inhibitor therapy.
See All 15 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Changes in bone mineral density in women with breast cancer receiving aromatase inhibitor therapy.
Changes in bone mineral density in women with breast cancer receiving aromatase inhibitor therapy. Breast Cancer Res Treat. 2018 Apr; 168(2):523-530.
View in:
PubMed
subject areas
Age Factors
Aged
Antineoplastic Agents, Hormonal
Aromatase Inhibitors
Bone Density
Breast Neoplasms
California
Chemotherapy, Adjuvant
Diphosphonates
Female
Follow-Up Studies
Humans
Mastectomy
Middle Aged
Osteoporosis
Postmenopause
Prevalence
Prospective Studies
Treatment Outcome
authors with profiles
Joan C. Lo, MD
Marilyn L. Kwan, PhD
Charles P. Quesenberry, PhD
Lawrence H. Kushi, ScD